| Autor: |
Shoji Takahashi, Yoshinobu Hata, Atsuro Terahara, Susumu Sakamoto, Fumitomo Sato, Keita Sato, Shinji Sakaguchi, Keishi Sugino, Yujiro Takai, Kazutoshi Isobe, Aki Mitsuda, Go Sano, Kazutoshi Shibuya, Sakae Homma, Keigo Takagi |
| Rok vydání: |
2012 |
| Předmět: |
|
| Zdroj: |
Asia-Pacific Journal of Clinical Oncology. 8:260-266 |
| ISSN: |
1743-7555 |
| Popis: |
Aim: The aim of this study was to clarify the relationship between pathological effects and the prognosis of patients with stage III non-small cell lung cancer (NSCLC) treated with induction chemoradiation. Methods: Patients who were untreated and potentially resectable with stage III NSCLC were enrolled. They received carboplatin and docetaxel with concurrent radiotherapy (5 × 2 Gy/week with a total dose of 40 Gy) followed by surgery. We assessed the relationship between the pathological effect (Ef) (Ef 1: slight pathological response, Ef 2: moderate pathological response, Ef 3: complete pathological response) and prognosis. Results: In all, 30 patients with stage III NSCLC (24 men and 6 women, mean age 60.7 years, 17 with adenocarcinomas and 13 with squamous cell carcinomas, 21 with clinical stage IIIA and nine with stage IIIB) participated in the trial and underwent induction chemoradiation. A total of 27 patients (90%) with complete response, partial response and stable disease had surgical resection. The pathological effect was Ef 1 and Ef 2 in 10 patients each, and Ef 3 in seven patients. Median survival was 10.9 months in patients with Ef 1 and 49.6 months in patients with Ef 2. Six out of seven Ef 3 patients are alive at the time of writing with a mean survival of 77.1 months (14–104 months). There was a significant difference in overall survival based on pathological effect rating (P = 0.0036). Conclusion: The Ef rating was well correlated with prognosis after induction chemoradiation. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
